Fig. 3From: Clinical impact of suboptimal RAASi therapy following an episode of hyperkalemiaRisk of cardiorenal composite outcome by change in RAASi treatment following HK episode: (a) the US, (b) Japan. CI confidence interval, HK hyperkalemia, RAASi renin-angiotensin-aldosterone system inhibitor. P-value for the differences between the groups: US, p < 0.001; Japan, p < 0.001Back to article page